Picard Medical, Inc. Operating Cash Flow
Picard Medical, Inc. (PMI) reported Operating Cash Flow of -$5.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- Picard Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.35M.
- Picard Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.80M.
- Picard Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.38M.
- Picard Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$5.15M 10-Q · filed 2026-08-19 | -$9.53M derived: sum of 3 quarters · filed 2026-08-19 | -$16.04M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | -$3.80M 10-Q · filed 2026-05-15 | -$8.18M derived: sum of 2 quarters · filed 2026-05-15 | -$14.69M derived: sum of 3 quarters · filed 2026-05-15 | -$17.23M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$4.38M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$10.89M derived: sum of 2 quarters · filed 2026-05-01 | -$13.43M derived: sum of 3 quarters · filed 2026-08-19 | -$15.67M S-1/A · filed 2026-05-01 |
| 2025-09-30 | -$6.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$9.05M derived: sum of 2 quarters · filed 2026-08-19 | -$11.30M 10-Q · filed 2025-11-14 | -$14.45M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | -$2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$4.78M 10-Q · filed 2026-08-19 | -$7.93M derived: sum of 3 quarters · filed 2026-08-19 | -$10.54M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | -$2.24M 10-Q · filed 2026-05-15 | -$5.39M derived: sum of 2 quarters · filed 2026-05-15 | -$8.00M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$3.15M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$5.76M derived: sum of 2 quarters · filed 2026-05-01 | -$11.87M S-1/A · filed 2026-05-01 | |
| 2024-09-30 | -$2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$8.72M 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$6.11M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |